State Street Corp Regenxbio Inc. Transaction History

State Street Corp

$2.59 Trillion
Q2 2025

A detailed history of State Street Corp transactions in Regenxbio Inc. stock. As of the latest transaction made, State Street Corp holds 1,843,645 shares of RGNX stock, worth $16.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,843,645

Previous 1,066,093 72.93%

Holding current value

$16.8 Million

Previous $7.62 Million 98.58%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$5.31 - $10.4 $4.13 Million - $8.09 Million	777,552 Added 72.93%	1,843,645 $15.1 Million
Q1 2025 May 15, 2025	SELL	$5.92 - $8.7 $6.63 Million - $9.74 Million	-1,119,758 Reduced 51.23%	1,066,093 $7.62 Million
Q4 2024 Feb 14, 2025	SELL	$7.23 - $11.56 $4.32 Million - $6.9 Million	-597,032 Reduced 21.45%	2,185,851 $16.9 Million
Q3 2024 Nov 14, 2024	SELL	$10.49 - $14.39 $947,792 - $1.3 Million	-90,352 Reduced 3.14%	2,782,883 $29.2 Million
Q2 2024 Aug 14, 2024	SELL	$11.51 - $21.53 $2.87 Million - $5.37 Million	-249,404 Reduced 7.99%	2,873,235 $33.6 Million
Q1 2024 May 15, 2024	BUY	$12.17 - $24.61 $5.98 Million - $12.1 Million	491,419 Added 18.68%	3,122,639 $65.8 Million
Q4 2023 Feb 14, 2024	BUY	$12.89 - $20.82 $1.65 Million - $2.66 Million	127,739 Added 5.1%	2,631,220 $47.2 Million
Q3 2023 Nov 14, 2023	SELL	$16.46 - $19.99 $4.26 Million - $5.17 Million	-258,635 Reduced 9.36%	2,503,481 $41.2 Million
Q2 2023 Aug 14, 2023	BUY	$17.23 - $21.71 $3.12 Million - $3.93 Million	180,853 Added 7.01%	2,762,116 $55.2 Million
Q1 2023 May 15, 2023	SELL	$18.08 - $24.55 $2.44 Million - $3.31 Million	-134,926 Reduced 4.97%	2,581,263 $48.8 Million
Q4 2022 Feb 14, 2023	BUY	$20.4 - $24.73 $1.96 Million - $2.38 Million	96,085 Added 3.67%	2,716,189 $61.6 Million
Q3 2022 Nov 15, 2022	SELL	$22.29 - $35.04 $4.04 Million - $6.36 Million	-181,390 Reduced 6.47%	2,620,104 $69.2 Million
Q2 2022 Aug 15, 2022	BUY	$19.35 - $35.04 $2.86 Million - $5.18 Million	147,728 Added 5.57%	2,801,494 $69.2 Million
Q1 2022 May 16, 2022	BUY	$24.62 - $34.31 $4.03 Million - $5.61 Million	163,513 Added 6.57%	2,653,766 $88.1 Million
Q4 2021 Feb 14, 2022	BUY	$30.19 - $40.28 $1.9 Million - $2.53 Million	62,815 Added 2.59%	2,490,253 $81.4 Million
Q3 2021 Nov 15, 2021	BUY	$29.09 - $45.68 $4.76 Million - $7.47 Million	163,557 Added 7.22%	2,427,438 $102 Million
Q2 2021 Aug 16, 2021	SELL	$32.46 - $40.48 $1.04 Million - $1.29 Million	-31,906 Reduced 1.39%	2,263,881 $88 Million
Q1 2021 May 17, 2021	BUY	$33.61 - $49.95 $15.9 Million - $23.7 Million	474,131 Added 26.03%	2,295,787 $78.3 Million
Q4 2020 Feb 16, 2021	SELL	$26.52 - $49.35 $8.55 Million - $15.9 Million	-322,241 Reduced 15.03%	1,821,656 $82.6 Million
Q3 2020 Nov 10, 2020	SELL	$27.01 - $40.26 $2.75 Million - $4.1 Million	-101,743 Reduced 4.53%	2,143,897 $59 Million
Q2 2020 Aug 14, 2020	BUY	$27.75 - $43.44 $7.74 Million - $12.1 Million	279,077 Added 14.19%	2,245,640 $82.7 Million
Q1 2020 May 11, 2020	BUY	$21.5 - $54.2 $42.3 Million - $107 Million	1,966,563 New	1,966,563 $63.7 Million

Others Institutions Holding RGNX

# of Institutions

181

Shares Held

45.1M

Call Options Held

103K

Put Options Held

100K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $393M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Regenxbio Inc. Transaction History